Andere Sprachen Avid Bioservices, Inc.

Aktien

A2JBKV

US05368M1062

CDMO

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:01 03.05.2024			% 5 Tage	% 1. Jan.
8,25 ^USD	+0,61 %		+12,70 %	+26,92 %

30.04.	AVID BIOSERVICES, INC. : RBC Capital Markets bekräftigt seine Kaufempfehlung	ZM
29.04.	Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Avid Bioservices: Fiscal Q3 Earnings Snapshot	24.04.
Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024	24.04.
Avid Bioservices, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	24.04.
North American Morning Briefing : Stock Futures -2-	19.04.
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO	12.04.
North American Morning Briefing : Investors on Edge as High-Stakes Jobs Report Awaited	05.04.
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO	05.04.
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO	27.03.
North American Morning Briefing : Stocks Struggle After New Records	22.03.
Avid Bioservices Receives Nasdaq Noncompliance Notice	20.03.
Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q	20.03.
North American Morning Briefing : Inflation Worries Continue to Weigh on Mood	15.03.
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors	14.03.
Avid Bioservices, Inc. (CDMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings	14.03.
Law Offices of Howard G. Smith Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors	14.03.
The Law Offices of Frank R. Cruz Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors	13.03.
Avid Bioservices, Inc. (CDMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings	08.03.
Avid Bioservices Prices $160 Million Convertible Notes Offering; Shares Slump	07.03.
CDMO LOSS ALERT: ROSEN, A LEADING LAW FIRM, Encourages Avid Bioservices, Inc. Investors to Inquire About Securities Class Action Investigation – CDMO	07.03.
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Buoyed by Powell's Comments	07.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Avid Bioservices, Inc.

Aktien

A2JBKV

US05368M1062

CDMO

Andere Sprachen

Filter